Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

PURPOSE: Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide can be used as a single-tablet regimen (STR, DRV/c/FTC/TAF) or multiple-tablet regimen (MTR, DRV/c+FTC/TAF) to treat patients with human immunodeficiency virus (HIV). This study described treatment patterns and predictors of ad...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Patient Prefer Adherence
Prif Awduron: Chow, Wing, Donga, Prina, Côté-Sergent, Aurélie, Rossi, Carmine, Lefebvre, Patrick, Lafeuille, Marie-Hélène, Hardy, Hélène, Emond, Bruno
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7695894/
https://ncbi.nlm.nih.gov/pubmed/33262581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S272211
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg